Menu
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Buy Currently
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Sample Portfolio
Sample Portfolio Analysis
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Account Requirements
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
Municipal Bond Presentation
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Normally Buy
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF® Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about Health & Science
Recent news which mentions Health & Science
< Previous
1
2
...
12
13
14
15
16
17
18
19
20
...
32
33
Next >
Healthy Returns: The first round of Medicare drug price negotiations is nearing an end
July 23, 2024
Tags
Health care industry
AstraZeneca PLC
Health & Science
From
CNBC.com News
Novo Nordisk's Wegovy weight loss drug wins UK approval for use as a heart treatment
July 23, 2024
Tags
Health care industry
Novo Nordisk A/S
Pharmaceuticals
From
CNBC.com News
Lawmakers introduce bipartisan bill aiming to crack down on drug middlemen as scrutiny ramps up
July 23, 2024
Tags
Politics
Biotech and Pharmaceuticals
Cigna Corp
From
CNBC.com News
Op-ed: How well can AI chatbots mimic doctors in a treatment setting? We put 5 to the test
July 18, 2024
Tags
Health & Science
Meta Platforms Inc
Commentary
From
CNBC.com News
A growing number of parents are refusing to give their children smartphones — and the movement is going global
July 17, 2024
Tags
Make It / Life
Parenting
Make It / Psychology and Relationships
From
CNBC.com News
Brain implant patient says OpenAI's tech helps him communicate with family
July 16, 2024
Tags
Internet
Science
Enterprise
From
CNBC.com News
Healthy Returns: Diabetes drug Ozempic may lower dementia risk, nicotine use
July 16, 2024
Tags
Eli Lilly and Co
Novo Nordisk A/S
Biotech and Pharmaceuticals
From
CNBC.com News
These are America's 10 worst states for quality of life in 2024
July 13, 2024
Tags
Child care
Child care costs
US: News
From
CNBC.com News
Inside the $43 million Veterans Affairs simulation hospital where doctors are piloting new tech
July 13, 2024
Tags
AI / Artificial Intelligence
Technology
Hospitals
From
CNBC.com News
Healthy Returns: Drugmakers are racing to develop more convenient weight loss pills
July 11, 2024
Tags
Health & Science
Health care industry
Biotech and Pharmaceuticals
From
CNBC.com News
Pfizer moves forward with once-daily version of weight loss pill after setbacks
July 11, 2024
Tags
Biotechnology
Eli Lilly and Co
US: News
From
CNBC.com News
Musk says next Neuralink brain implant expected soon, despite issues with the first patient
July 10, 2024
Tags
Science
Internet
Enterprise
From
CNBC.com News
FTC to sue drug middlemen over prices of medications including insulin
July 10, 2024
Tags
Business News
Health care industry
Social issues
From
CNBC.com News
Samsung launches the Galaxy Ring — a first-of-its-kind product for the tech giant
July 10, 2024
Tags
Health & Science
Apple Inc
Smartphones
From
CNBC.com News
Novo Nordisk shares shrug off concerns over study linking weight loss drugs to rare eye condition
July 04, 2024
Tags
US: News
Biotech and Pharmaceuticals
Science
From
CNBC.com News
Healthy Returns: Brain implant company Paradromics launches patient registry ahead of human trial
July 03, 2024
Tags
Cigna Corp
Biotech and Pharmaceuticals
Viking Therapeutics Inc
From
CNBC.com News
Can't understand your teenager's behavior? Psychologists have tips to offer
July 02, 2024
Tags
Movies and Entertainment
Parenting
Movies
From
CNBC.com News
FDA approves Eli Lilly Alzheimer’s drug, expanding treatment options in the U.S.
July 02, 2024
Tags
Science
Biotech and Pharmaceuticals
Health care industry
From
CNBC.com News
Pfizer struggles to claw back faith with Wall Street and its employees as it recovers from the Covid decline
June 28, 2024
Tags
Biotech and Pharmaceuticals
Vaccinations
Labor economy
From
CNBC.com News
'Alarmingly high': E.coli levels discovered in River Thames ahead of famous regatta
June 28, 2024
Tags
Health care industry
Europe News
Europe: Top News And Analysis
From
CNBC.com News
Drug prices have risen almost 40% over the last decade, according to a new tracker
June 27, 2024
Tags
Health Insurance
Drug Retail
Health & Science
From
CNBC.com News
Walgreens slashes profit guidance, citing 'challenging' environment for consumers and pharmacies
June 27, 2024
Tags
Business
Health & Science
Pharmaceuticals
From
CNBC.com News
Healthy Returns: Eli Lilly, other drugmakers show off encouraging weight loss drug data
June 26, 2024
Tags
Biotech and Pharmaceuticals
Science
Oracle Corp
From
CNBC.com News
Biden administration to lower costs for 64 drugs through inflation penalties on drugmakers
June 26, 2024
Tags
Social issues
Breaking news
Health care industry
From
CNBC.com News
Masimo activist Politan presents 'last chance' for shareholders to force change at med-tech company
June 26, 2024
Tags
Health & Science
Masimo Corp
Apple Inc
From
CNBC.com News
Novo Nordisk to build $4.1 billion North Carolina facility to boost output of Wegovy, Ozempic
June 24, 2024
Tags
US: News
Biotech and Pharmaceuticals
Novo Nordisk A/S
From
CNBC.com News
Eli Lilly expects FDA decision on weight loss drug Zepbound for sleep apnea as early as end of the year
June 21, 2024
Tags
Biotech and Pharmaceuticals
Science
US: News
From
CNBC.com News
Neuralink competitor Paradromics gears up to test its brain implant on humans
June 21, 2024
Tags
Start/ups
The Edge
Software
From
CNBC.com News
Gilead’s twice-yearly shot to prevent HIV succeeds in late-stage trial
June 20, 2024
Tags
Gilead Sciences Inc
Biotech and Pharmaceuticals
Health & Science
From
CNBC.com News
Healthy Returns: More U.S. employers are now covering GLP-1s for weight loss
June 18, 2024
Tags
Eli Lilly and Co
Novo Nordisk A/S
Labor economy
From
CNBC.com News
< Previous
1
2
...
12
13
14
15
16
17
18
19
20
...
32
33
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.